Real world experience with cyclin dependent kinase inhibitors in metastatic breast cancer in India

Anindya Mukherjee, Pankaj Goyal, Rupal Tripathi, Sumit Goyal, Ullas Batra, Vineet Talwar, Varun Goel, Arpit Jain · 2026

Read Real world experience with cyclin dependent kinase inhibitors in metastatic breast cancer in India by Anindya Mukherjee, Pankaj Goyal, Rupal Tripathi, Sumit Goyal, Ullas Batra, Vineet Talwar, Varun Goel, Arpit Jain (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0349196.txt.

Description

Anindya Mukherjee and colleagues reviewed hospital records for Indian patients with advanced breast cancer treated with two modern hormone-blocking partner drugs, palbociclib and ribociclib, between twenty twenty-one and twenty twenty-three. These drugs, used with hormone therapy, are standard in wealthy countries, but published experience from Indian clinics is scarce. The team measured how long the cancer stayed controlled and which patient traits predicted doing better.

Patients who were fitter at the start kept their disease controlled longer. So did those whose cancer was found already spread. The same held for patients who received the drugs with their first hormone treatment, and for those who had never had chemotherapy. Control often lasted beyond twenty months. Formal analysis confirmed fitness, treatment order, and past chemotherapy as the strongest predictors. The authors say everyday Indian outcomes match trial expectations when the right patients get the drugs early.

Catalog record

CREATORAnindya Mukherjee, Pankaj Goyal, Rupal Tripathi, Sumit Goyal, Ullas Batra, Vineet Talwar, Varun Goel, Arpit Jain
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE25216
LICENSECC_BY
RIGHTSCC BY
SOURCEPLOS

Source: https://doi.org/10.1371/journal.pone.0349196

Browse the full library · About the Tower of Babel